share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Arduini Peter J

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施貴寶 | 4：持股變動聲明
SEC announcement ·  04/03 06:41
牛牛AI助理已提取核心訊息
Peter J Arduini, a reporting person for Bristol-Myers Squibb (BMY), has engaged in a transaction involving the company's stock. The action took place on March 31, 2024. However, the specific details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting ownership stake, have not been disclosed. This information is critical for investors to understand the implications of the transaction on their investment decisions.
Peter J Arduini, a reporting person for Bristol-Myers Squibb (BMY), has engaged in a transaction involving the company's stock. The action took place on March 31, 2024. However, the specific details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting ownership stake, have not been disclosed. This information is critical for investors to understand the implications of the transaction on their investment decisions.
百時美施貴寶（BMY）的舉報人彼得·阿杜尼參與了一項涉及該公司股票的交易。該行動於 2024 年 3 月 31 日進行。但是，有關交易性質的具體細節，例如所涉及的股票數量、交易價格以及由此產生的所有權，尚未披露。這些信息對於投資者了解交易對其投資決策的影響至關重要。
百時美施貴寶（BMY）的舉報人彼得·阿杜尼參與了一項涉及該公司股票的交易。該行動於 2024 年 3 月 31 日進行。但是，有關交易性質的具體細節，例如所涉及的股票數量、交易價格以及由此產生的所有權，尚未披露。這些信息對於投資者了解交易對其投資決策的影響至關重要。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。